glp 1 gip 1 Dr.Syed Targeting GLP-1, GIP & GCG
Description
Additionally, it was demonstrated that the long-acting triagonist protected against Parkinson disease in mice by attenuating microglial activation and inflammation in the specific brain regions [31]
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
But what about microdosing taking very small doses long-term
There have been reports of these drugs inducing pancreatitis and recent suggestions that they may predispose to pancreatic cancer
